Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,046 | $2.808 | $19,785 | 474,862 (Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:05 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.115 | $12 | 474,462 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:44 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,229 | $1.152 | $8,328 | 474,473 (Direct) | View |
| 2025-04-17 Sale | 2025-04-21 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 8 | $0.964 | $8 | 481,702 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,535 | $1.483 | $5,242 | 481,710 (Direct) | View |
| 2025-02-19 Sale | 2025-02-20 4:50 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.86 | $20 | 240,671 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:38 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 9 | $2.265 | $20 | 240,682 (Direct) | View |
| 2024-12-17 Sale | 2024-12-18 4:14 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,245 | $2.424 | $7,866 | 240,691 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-14 Option Award | 2025-03-17 5:16 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 451,000 | $0 | 698,245 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:32 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 370,000 | $0 | 443,936 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:21 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 48,200 | $0 | 112,936 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-12 4:07 pm | N/A 2032-12-09 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 110,000 | $0 | 129,771 (Direct) | View |
Ownership | 2022-11-16 4:11 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 0 | $0 | 19,771 (Direct) | View |